
Chimera Investment Corporation
Real Estate · USD
Price
$12.86
Cap
$1.1B
Earnings
2/4 beat
30d Trend
+0%
Upper half of range — momentum is positive
Target range: $13 – $15.5 (consensus: $14.5)
Consensus: Hold
Earnings history
Q4 2025
BEAT
0.53 vs 0.5
Q3 2025
MISS
0.37 vs 0.46
Q2 2025
MISS
0.39 vs 0.46
Q1 2025
BEAT
0.41 vs 0.4
Key macro factors
Interest Rate Environment: As a mortgage REIT, Chimera Investment Corporation's profitability is highly sensitive to changes in interest rates. Rising or sustained high interest rates can increase the company's borrowing costs, thereby compressing its net interest margins, which are critical to its income generation.
Economic Growth and Housing Market Health: A robust U.S. economy, evidenced by job growth and low unemployment, generally supports the housing market and mortgage demand. This can positively impact Chimera's portfolio of residential mortgage loans and mortgage-backed securities. However, any slowdown in global growth, potentially exacerbated by geopolitical conflicts, could eventually affect the U.S. economy and subsequently the housing sector and credit quality.
Credit Quality and Mortgage Defaults: The financial health of borrowers and the overall stability of the housing market directly influence the credit quality of Chimera's mortgage assets. Economic uncertainty, potentially stemming from global conflicts or inflation, could lead to increased mortgage delinquencies or defaults, negatively affecting the value of the company's investments and its overall financial performance.
Chimera Investment Corporation is an internally managed real estate investment trust (REIT) focused on mortgage credit, aiming to provide attractive risk-adjusted returns and distributable income through investments in a diversified range of mortgage assets, including residential mortgage loans, Agency and Non-Agency residential mortgage-backed securities (RMBS), and other real estate-related assets.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
